BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24992043)

  • 1. The formation of cortical actin arrays in human trabecular meshwork cells in response to cytoskeletal disruption.
    Murphy KC; Morgan JT; Wood JA; Sadeli A; Murphy CJ; Russell P
    Exp Cell Res; 2014 Oct; 328(1):164-171. PubMed ID: 24992043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose latrunculin-A inhibits dexamethasone-induced changes in the actin cytoskeleton and alters extracellular matrix protein expression in cultured human trabecular meshwork cells.
    Liu X; Wu Z; Sheibani N; Brandt CR; Polansky JR; Kaufman PL
    Exp Eye Res; 2003 Aug; 77(2):181-8. PubMed ID: 12873448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of actin cytoskeletal integrity on matrix metalloproteinase-2 activation in cultured human trabecular meshwork cells.
    Sanka K; Maddala R; Epstein DL; Rao PV
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2105-14. PubMed ID: 17460268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of latrunculin-A on morphology and actin-associated adhesions of cultured human trabecular meshwork cells.
    Cai S; Liu X; Glasser A; Volberg T; Filla M; Geiger B; Polansky JR; Kaufman PL
    Mol Vis; 2000 Jul; 6():132-43. PubMed ID: 10930474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substratum stiffness and latrunculin B modulate the gene expression of the mechanotransducers YAP and TAZ in human trabecular meshwork cells.
    Thomasy SM; Morgan JT; Wood JA; Murphy CJ; Russell P
    Exp Eye Res; 2013 Aug; 113():66-73. PubMed ID: 23727052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substratum compliance regulates human trabecular meshwork cell behaviors and response to latrunculin B.
    Wood JA; McKee CT; Thomasy SM; Fischer ME; Shah NM; Murphy CJ; Russell P
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9298-303. PubMed ID: 22064990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substratum stiffness and latrunculin B regulate matrix gene and protein expression in human trabecular meshwork cells.
    Thomasy SM; Wood JA; Kass PH; Murphy CJ; Russell P
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):952-8. PubMed ID: 22247475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acto-myosin drug effects and aqueous outflow function.
    Epstein DL; Rowlette LL; Roberts BC
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):74-81. PubMed ID: 9888429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
    Rao PV; Deng PF; Kumar J; Epstein DL
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of latrunculin-B on outflow facility in monkeys.
    Peterson JA; Tian B; Geiger B; Kaufman PL
    Exp Eye Res; 2000 Mar; 70(3):307-13. PubMed ID: 10712817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latrunculin B effects on trabecular meshwork and corneal endothelial morphology in monkeys.
    Sabanay I; Tian B; Gabelt BT; Geiger B; Kaufman PL
    Exp Eye Res; 2006 Feb; 82(2):236-46. PubMed ID: 16054137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latrunculin-A increases outflow facility in the monkey.
    Peterson JA; Tian B; Bershadsky AD; Volberg T; Gangnon RE; Spector I; Geiger B; Kaufman PL
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):931-41. PubMed ID: 10102290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caldesmon effects on the actin cytoskeleton and cell adhesion in cultured HTM cells.
    Grosheva I; Vittitow JL; Goichberg P; Gabelt BT; Kaufman PL; Borrás T; Geiger B; Bershadsky AD
    Exp Eye Res; 2006 Jun; 82(6):945-58. PubMed ID: 16679125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho-kinase-mediated suppression of KDR current in cerebral arteries requires an intact actin cytoskeleton.
    Luykenaar KD; El-Rahman RA; Walsh MP; Welsh DG
    Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H917-26. PubMed ID: 19218502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of biophysical attributes of the ocular trabecular meshwork associated with glaucoma on the cell response to therapeutic agents.
    McKee CT; Wood JA; Shah NM; Fischer ME; Reilly CM; Murphy CJ; Russell P
    Biomaterials; 2011 Mar; 32(9):2417-23. PubMed ID: 21220171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of endothelin-1 on human trabecular meshwork cell contraction. an in vitro cell culture model.
    Cellini M; Versura P; Trerè D; Campos EC
    Ophthalmic Res; 2005; 37(1):43-9. PubMed ID: 15637421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility.
    Honjo M; Tanihara H; Inatani M; Kido N; Sawamura T; Yue BY; Narumiya S; Honda Y
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):137-44. PubMed ID: 11133858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latrunculin B and substratum stiffness regulate corneal fibroblast to myofibroblast transformation.
    Thomasy SM; Raghunathan VK; Miyagi H; Evashenk AT; Sermeno JC; Tripp GK; Morgan JT; Murphy CJ
    Exp Eye Res; 2018 May; 170():101-107. PubMed ID: 29421383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tissue-engineered human trabecular meshwork hydrogel for advanced glaucoma disease modeling.
    Li H; Bagué T; Kirschner A; Strat AN; Roberts H; Weisenthal RW; Patteson AE; Annabi N; Stamer WD; Ganapathy PS; Herberg S
    Exp Eye Res; 2021 Apr; 205():108472. PubMed ID: 33516765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGFβ2-induced outflow alterations in a bioengineered trabecular meshwork are offset by a rho-associated kinase inhibitor.
    Torrejon KY; Papke EL; Halman JR; Bergkvist M; Danias J; Sharfstein ST; Xie Y
    Sci Rep; 2016 Dec; 6():38319. PubMed ID: 27924833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.